Clinical Trials Browser

Mast Cell Activation Disorders × Imatinib Mesylate × Myeloid × Clear all

NCT01297777 2016-08-29

Imatinib in KIT-negative Systemic Mastocytosis

Phase 4 Completed

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic